[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Botulism Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 40 pages | ID: B525EE351E45EN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Botulism Drug pipeline report- 2020 is an annual R&D review of Botulism pipeline candidates. The report presents the current status of all major Botulism therapeutic compounds. Detailed insights into Botulism pipeline development, current status, companies, drug profiles and Botulism preclinical and clinical trials are included.

2020 Botulism Pipeline Market Insights
Botulism disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Botulism therapies, pipeline by phase and others are included.

Botulism pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Botulism Therapeutic Drug candidates
Both active and inactive Botulism pipeline drug candidates are included in the report

Botulism Clinical Trials and preclinical Studies
Botulism In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Botulism pipeline market developments
Botulism Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Botulism pipeline companies in active development
The report analyzes Botulism pipeline of the below companies-

CytoDel Inc, Hawaii Biotech Inc, Inventox Inc, Ology Bioservices Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
4 Companies investing in Botulism pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Botulism pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. BOTULISM PIPELINE MARKET INSIGHTS, 2020

1.1 Botulism Disease Overview
1.2 Botulism Drug Pipeline Snapshot, 2020
  1.2.1 Botulism Pipeline Drugs by Phase
  1.2.2 Botulism Pipeline Drugs by Company
  1.2.3 Botulism Pipeline Drugs by Mechanism of Action
  1.2.4 Botulism Pipeline Drugs by Route of Administration

2. BOTULISM COMPANY WISE PIPELINE DETAILS

CytoDel Inc Botulism Pipeline Drugs
  Company Profile
  Drug Candidate Details
Hawaii Biotech Inc Botulism Pipeline Drugs
  Company Profile
  Drug Candidate Details
Inventox Inc Botulism Pipeline Drugs
  Company Profile
  Drug Candidate Details
Ology Bioservices Inc Botulism Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. BOTULISM DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. BOTULISM PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications